Liquidia Corporation Common Stock

LQDANASDAQ • USD
ThemeBiotech - Drug Development›Rare Disease Therapeutics
61.85 USD
↘ 0.69 (1.10%)AT CLOSE (11:59 AM EDT)
63.77
↗ 1.92 (3.10%)
POST MARKET (AS OF 08:00 PM EDT)
Post Market
AS OF 08:00 PM EDT
63.77
↗ 1.92 (3.10%)
🔴Market: CLOSED
Open?$62.76
High?$65.99
Low?$61.39
Prev. Close?$62.54
Volume?1.7M
Avg. Volume?1.7M
VWAP?$62.74
Rel. Volume?1.03x
Bid / Ask
Bid?$51.85 × 100
Ask?$72.35 × 100
Spread?$20.50
Midpoint?$62.10
Valuation & Ratios
Market Cap?5.5B
Shares Out?88.9M
Float?65.8M
Float %?75.7%
P/E Ratio?246.59
P/B Ratio?50.66
EPS?$0.25
Dividend?0.00%
Ex-Dividend?N/A

Liquidia Corporation Common Stock (LQDA) trades at $61.85 per share. Technical and fundamental signals align bullish — technicals rate "Buy" while fundamentals indicate "Buy". Key drivers include a robust Altman Z-Score, exceptional Return on Equity (20.5%), a bullish Golden Cross on the moving averages and bullish moving average alignment. Furthermore, LQDA is currently richly valued, trading at a premium to sector peers across key valuation metrics.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.
Themes
Biotech - Drug Development›Rare Disease Therapeutics
Employees
216
Market Cap
5.5B
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.liquidia.com
Listed
2018-07-26
Address
419 DAVIS DRIVE, SUITE 100
MORRISVILLE, NC 27560
Phone: 919.328.4400
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?
60
Z-Score?
100
Momentum?
97
Short Sent.?
51
Piotroski F-Score?5/9Mixed
Altman Z-Score?10.91Safe
Confidence?67%Moderate
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?15.51%High
Short Interest?10.2M
Days to Cover?4.9
Free Float65.8M
Avg Daily Volume2.1M
Settlement Date2026-05-15
Financial Health
Current Ratio?2.22Strong
Quick Ratio?2.03Strong
Cash Ratio?1.49Strong
Debt/Equity?1.64High
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score
33/100
P/E?
Peers
100
S&P
3
246.6PRICEY▾
P/B?
Peers
100
S&P
3
50.66HIGH▾
P/S?
Peers
100
S&P
3
19.09HIGH▾
P/FCF?
Peers
100
S&P
3
133.7PRICEY▾
EV/EBITDA?
Peers
100
S&P
3
115.8HIGH▾
EV/Sales?
Peers
100
S&P
3
18.94HIGH▾
Returns & Efficiency
ROE?
Peers
50
S&P
67
20.5%STRONG▾
ROA?
Peers
50
S&P
50
5.6%FAIR▾
Cash Flow & Enterprise
FCF?$41.1M
Enterprise Value?$5.5B
Fundamentals ratios updated end of day
MarketsMoversWatchlist